Posted by Michael Wonder on 26 Jan 2024
Four dose Mounjaro “KwikPen” approved by MHRA for diabetes and weight management
25 January 2024 - The new presentation of Mounjaro gives four doses for once a week treatment over a month.
Mounjaro KwikPen is approved to treat adults with type 2 diabetes and for weight management in adult patients with a BMI of 30kg/m² or more (obesity), as well as those with a BMI between 27-30kg/m² (overweight) who also have weight-related health problems such as pre-diabetes, high blood pressure, high cholesterol, or heart problems.
